中国现代药物应用
中國現代藥物應用
중국현대약물응용
CHINESE JOURNAL OF MODERN DRUG APPLICATION
2015年
11期
41-43
,共3页
无创气道正压通气%生脉注射液%慢性心力衰竭%心率变异性
無創氣道正壓通氣%生脈註射液%慢性心力衰竭%心率變異性
무창기도정압통기%생맥주사액%만성심력쇠갈%심솔변이성
Non-invasive positive airway pressure ventilation%Shengmai injection%Chronic heart failure%Heart rate variability
目的:探讨无创气道正压通气联合生脉注射液对慢性心力衰竭(CHF)患者心功能以及心率的影响。方法80例慢性心力衰竭患者随机分为治疗组和对照组,各40例。对照组采用常规治疗,治疗组在对照组治疗基础上,给予无创气道正压通气联合生脉注射液治疗,记录治疗前后患者的症状、心脏功能指标[左室射血分数(LVEF)、心输出量(CO)、心搏出量(SV)]、血气指标[血氧饱和度(SaO2)、氧分压(PO2)、二氧化碳分压(PCO2)]情况。结果两组患者治疗后临床症状和SaO2、PO2、PCO2均有所改善, CO、SV、LVEF均明显增高,且治疗组的效果明显优于对照组(P<0.05)。结论与传统治疗相比,无创气道正压通气联合生脉注射液治疗且能明显改善慢性心力衰竭患者心功能及心率。
目的:探討無創氣道正壓通氣聯閤生脈註射液對慢性心力衰竭(CHF)患者心功能以及心率的影響。方法80例慢性心力衰竭患者隨機分為治療組和對照組,各40例。對照組採用常規治療,治療組在對照組治療基礎上,給予無創氣道正壓通氣聯閤生脈註射液治療,記錄治療前後患者的癥狀、心髒功能指標[左室射血分數(LVEF)、心輸齣量(CO)、心搏齣量(SV)]、血氣指標[血氧飽和度(SaO2)、氧分壓(PO2)、二氧化碳分壓(PCO2)]情況。結果兩組患者治療後臨床癥狀和SaO2、PO2、PCO2均有所改善, CO、SV、LVEF均明顯增高,且治療組的效果明顯優于對照組(P<0.05)。結論與傳統治療相比,無創氣道正壓通氣聯閤生脈註射液治療且能明顯改善慢性心力衰竭患者心功能及心率。
목적:탐토무창기도정압통기연합생맥주사액대만성심력쇠갈(CHF)환자심공능이급심솔적영향。방법80례만성심력쇠갈환자수궤분위치료조화대조조,각40례。대조조채용상규치료,치료조재대조조치료기출상,급여무창기도정압통기연합생맥주사액치료,기록치료전후환자적증상、심장공능지표[좌실사혈분수(LVEF)、심수출량(CO)、심박출량(SV)]、혈기지표[혈양포화도(SaO2)、양분압(PO2)、이양화탄분압(PCO2)]정황。결과량조환자치료후림상증상화SaO2、PO2、PCO2균유소개선, CO、SV、LVEF균명현증고,차치료조적효과명현우우대조조(P<0.05)。결론여전통치료상비,무창기도정압통기연합생맥주사액치료차능명현개선만성심력쇠갈환자심공능급심솔。
Objective To investigate influence of non-invasive positive airway pressure ventilation combined with Shengmai injection on cardiac function and heart rate in chronic heart failure (CHF) patients. Methods A total of 80 chronic heart failure patients were randomly divided into treatment group and control group, with 40 cases in each group. The control group received conventional treatment, and the treatment group received additional non-invasive positive airway pressure ventilation combined with Shengmai injection. Records were made on symptoms, cardiac function indexes [left ventricular ejection fraction (LVEF), cardiac output (CO), stroke volume (SV)], and blood gas indexes [oxyhemoglobin saturation (SaO2), partial pressure of oxygen (PO2), partial pressure of carbon dioxide (PCO2)] before and after treatment. Results Both groups had improved clinical symptoms, SaO2, PO2, and PCO2, and their CO, SV, and LVEF were all obviously increased. The treatment group had much better effects than the control group (P<0.05). Conclusion Compared with traditional treatment, non-invasive positive airway pressure ventilation combined with Shengmai injection for treatment can effectively improve cardiac function and heart rate in chronic heart failure patients.